Serina Therapeutics, Inc.
SER
$5.65
$0.152.73%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.45M | -4.81M | -2.74M | 1.41M | 5.20M |
| Total Depreciation and Amortization | 16.00K | 17.00K | 56.00K | 56.00K | 57.00K |
| Total Amortization of Deferred Charges | -- | -- | 8.00K | 8.00K | 307.00K |
| Total Other Non-Cash Items | 1.98M | 19.00K | -1.74M | -5.38M | -8.79M |
| Change in Net Operating Assets | 706.00K | 455.00K | -172.00K | 943.00K | -4.79M |
| Cash from Operations | -3.75M | -4.32M | -4.59M | -2.96M | -8.01M |
| Capital Expenditure | -46.00K | -- | -5.00K | -3.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -46.00K | -- | -5.00K | -3.00K | 0.00 |
| Total Debt Issued | -- | -- | 110.00K | 8.00K | 525.00K |
| Total Debt Repaid | -- | -- | -1.00K | -8.00K | -146.00K |
| Issuance of Common Stock | 5.57M | 1.00K | 4.92M | 86.00K | 4.99M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 4.92M | 0.00 | 0.00 | 0.00 |
| Cash from Financing | 5.57M | 4.92M | 5.03M | 86.00K | 5.37M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.77M | 595.00K | 437.00K | -2.88M | -2.64M |